Dutch-based TargED raises €21.5 million Series A extension to advance targeted treatments for thrombotic diseases | EU-Startups
Dutch clinical-stage BioTech company TargED Biopharmaceuticals has announced the closing of a €21.5 million Series A extension financing to accelerate the
18 Dec 06:45 · EU-Startups